Zeria Pharmaceutical Co (TSE:4559) Accounts Payable & Accrued Expense : 円5,899 Mil (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co Accounts Payable & Accrued Expense?

Zeria Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Jun. 2023 (円4,160 Mil) to Sep. 2023 (円4,795 Mil) and increased from Sep. 2023 (円4,795 Mil) to Dec. 2023 (円5,899 Mil).

Zeria Pharmaceutical Co's annual accounts payable & accrued expense increased from Mar. 2022 (円2,508 Mil) to Mar. 2023 (円2,745 Mil) and increased from Mar. 2023 (円2,745 Mil) to Mar. 2024 (円5,241 Mil).

Zeria Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zeria Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zeria Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,837.01

2,256.53

2,507.89

2,745.23

5,241.16

Zeria Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,745.23	4,159.61	4,795.08	5,899.21	5,241.16

Zeria Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zeria Pharmaceutical Co (TSE:4559) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351

Website

http://www.zeria.co.jp

Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co (TSE:4559) Headlines

No Headlines